tiprankstipranks
Trending News
More News >
Evogene (EVGN)
NASDAQ:EVGN
US Market

Evogene (EVGN) Financial Statements

Compare
641 Followers

Evogene Financial Overview

Evogene's market cap is currently $9.15M. The company's EPS TTM is $0.444; its P/E ratio is -2.14; Evogene is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 8.51M$ 5.64M$ 1.68M$ 930.00K$ 1.04M
Gross Profit$ 3.39M$ 1.40M$ -1.77M$ -2.07M$ -2.26M
Operating Income$ -21.73M$ -26.39M$ -29.71M$ -31.49M$ -26.84M
EBITDA$ -15.38M$ -23.20M$ -26.93M$ -27.80M$ -23.18M
Net Income$ -16.48M$ -23.88M$ -26.64M$ -27.79M$ -23.37M
Balance Sheet
Cash & Short-Term Investments$ 15.31M$ 31.06M$ 35.35M$ 53.87M$ 48.23M
Total Assets$ 39.86M$ 51.10M$ 56.13M$ 76.30M$ 71.92M
Total Debt$ 12.87M$ 11.51M$ 11.93M$ 2.67M$ 2.44M
Net Debt$ -2.43M$ -9.27M$ -17.05M$ -29.66M$ -43.79M
Total Liabilities$ 25.03M$ 22.42M$ 21.34M$ 12.88M$ 15.03M
Stockholders' Equity$ -1.45M$ 12.05M$ 27.93M$ 53.65M$ 46.05M
Cash Flow
Free Cash Flow$ -20.33M$ -22.36M$ -24.85M$ -25.56M$ -20.20M
Operating Cash Flow$ -19.70M$ -21.58M$ -23.68M$ -24.84M$ -19.51M
Investing Cash Flow$ 9.62M$ -4.54M$ 13.27M$ -20.44M$ 9.41M
Financing Cash Flow$ 4.66M$ 18.15M$ 9.34M$ 30.28M$ 20.37M
Currency in USD

Evogene Earnings and Revenue History

Evogene Debt to Assets

Evogene Cash Flow

Evogene Forecast EPS vs Actual EPS